Materials·Specialty Chemicals·$25.3B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.64 | N/A | -14.32% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.64 | N/A | -14.32% |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Overall, management expressed caution regarding market conditions. They highlighted the need for strategic adjustments moving forward.
Management acknowledged the challenges faced in the quarter.
They emphasized a focus on cost control and operational efficiency.
SQM's earnings report indicates a weaker performance than expected, particularly in EPS, which fell short by over 14%. The stock reacted negatively, dropping 2.14% in response to the disappointing results. Investors may be concerned about the company's ability to navigate current market challenges without updated guidance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
ACADIA HEALTHCARE CO
Feb 25, 2026